Viking Therapeutics (VKTX) Other Gross PP&E Adjustments (2019 - 2025)
Viking Therapeutics' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$87000.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 94.29% year-over-year to -$87000.0; the TTM value through Dec 2025 reached -$87000.0, up 94.29%, while the annual FY2025 figure was -$87000.0, 94.29% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$87000.0 at Viking Therapeutics, up from -$687000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$87000.0 in Q4 2025 and bottomed at -$1.8 million in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$1.3 million (2023), against an average of -$1.1 million.
- The largest annual shift saw Other Gross PP&E Adjustments plummeted 1443.14% in 2022 before it skyrocketed 94.29% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$223000.0 in 2021, then tumbled by 691.48% to -$1.8 million in 2022, then grew by 15.98% to -$1.5 million in 2023, then fell by 2.76% to -$1.5 million in 2024, then surged by 94.29% to -$87000.0 in 2025.
- Per Business Quant, the three most recent readings for VKTX's Other Gross PP&E Adjustments are -$87000.0 (Q4 2025), -$687000.0 (Q3 2025), and -$1.0 million (Q2 2025).